罗库的安全性评估和子组分析 (基于性别和年龄):来自FAERS数据库的现实世界药监测研究
Xu Cheng1, Yongqiu Xie1, Zengzhen Yin2
1Department of Anesthesiology, Xiangya Hospital of Central South University, Changsha, Hunan, China; National Clinical Research Center for Geriatric Disorders (Xiangya Hospital), Changsha, China.
European journal of pharmacology
|November 9, 2025
概括
罗库的使用与过敏反应和心脏骤停等严重不良事件有关,特别是在老年人中. 医疗专业人员应谨慎行事,并密切监测患者是否存在这些风险.
科学领域:
- 药物监督 药物监督 药物监督
- 药品安全 药品安全
- 临床药理学 临床药理学
背景情况:
- 由于先前的研究样本大小小小,对罗库的不良事件的证据有限.
- 罗库可能引起严重不良反应的可能性在很大程度上仍未被描述.
- 本研究使用大型现实世界数据库调查与rocuronium相关的不良事件.
研究的目的:
- 从FAERS数据库分析与罗库相关的不良事件.
- 为了确定常见和意想不到的对罗库的不良反应.
- 为了探索与罗库相关的不良事件的人口差异.
主要方法:
- 从FAERS数据库中收集了2004年第一季度到2024年第二季度对罗库的不良事件数据.
- 信号量化技术包括ROR,PRR,BCPNN和EBGM用于分析.
- 研究了不良事件报告中的基于性别和年龄的差异.
主要成果:
- 在3316份报告中,在23个器官系统类别中发现了191种不同的不良反应.
- 常见的不良事件包括过敏反应,残留性,肌病和肺血管抵抗增加.
- 观察到一些意想不到的反应,如获得的纤维蛋白发育不良症,恶性热量升高和心脏骤停. 危及生命的事件,如急性心力衰竭和肺,在老年患者中更为频繁. 过敏性休克,过敏反应和心脏骤停是导致死亡的主要原因.
结论:
- 建议在使用罗库时谨慎使用,特别是在老年人群中.
- 调查结果有助于早期识别与罗库相关的不良反应.
- 这项研究为未来的研究和药物安全监管提供了宝贵的参考资料.
相关概念视频
01:15Drug Dosing: Geriatric Patients
215
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
215
01:12Hazard Ratio
554
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
554
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
180
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
141
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
141
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
226
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
226
01:19Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K